CSL Ltd. (CSLLY)
35.00
+0.24
(+0.69%)
USD |
OTCM |
Oct 29, 16:00
CSL Price : 35.00 for Oct. 29, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | 34.81 | 35.00 | 34.68 | 35.00 | 43225.00 |
| Oct 28, 2026 | 35.26 | 35.60 | 34.66 | 34.76 | 43163.00 |
| Oct 27, 2026 | 34.58 | 34.64 | 34.45 | 34.64 | 39949.00 |
| Oct 26, 2026 | 34.15 | 34.26 | 34.07 | 34.16 | 63281.00 |
| Oct 23, 2026 | 35.14 | 35.14 | 34.29 | 34.60 | 27820.00 |
| Oct 22, 2026 | 34.04 | 34.53 | 34.04 | 34.40 | 41362.00 |
| Oct 21, 2026 | 35.00 | 35.19 | 34.26 | 34.28 | 51543.00 |
| Oct 20, 2026 | 35.64 | 35.64 | 34.00 | 34.49 | 55482.00 |
| Oct 19, 2026 | 33.55 | 33.81 | 33.55 | 33.60 | 38928.00 |
| Oct 16, 2026 | 33.35 | 33.48 | 33.22 | 33.35 | 36626.00 |
| Oct 15, 2026 | 31.11 | 32.60 | 31.11 | 32.60 | 94363.00 |
| Oct 14, 2026 | 33.60 | 33.60 | 31.71 | 32.27 | 68946.00 |
| Oct 13, 2026 | 32.31 | 32.31 | 32.01 | 32.17 | 51753.00 |
| Oct 12, 2026 | 32.07 | 32.84 | 32.07 | 32.21 | 45998.00 |
| Oct 09, 2026 | 30.85 | 32.29 | 30.85 | 32.21 | 46351.00 |
| Oct 08, 2026 | 31.28 | 31.64 | 31.28 | 31.52 | 86219.00 |
| Oct 07, 2026 | 32.14 | 32.14 | 31.30 | 31.51 | 65057.00 |
| Oct 06, 2026 | 31.26 | 31.30 | 31.08 | 31.17 | 48610.00 |
| Oct 05, 2026 | 30.75 | 30.97 | 30.73 | 30.92 | 52100.00 |
| Oct 02, 2026 | 31.05 | 31.05 | 30.39 | 30.54 | 51439.00 |
| Oct 01, 2026 | 32.14 | 32.14 | 30.82 | 30.94 | 127525.0 |
| Sep 30, 2026 | 31.53 | 32.48 | 31.53 | 31.94 | 54107.00 |
| Sep 29, 2026 | 31.80 | 31.91 | 31.68 | 31.91 | 71208.00 |
| Sep 28, 2026 | 31.79 | 32.05 | 31.11 | 32.00 | 64543.00 |
| Sep 25, 2026 | 31.16 | 31.25 | 30.95 | 31.17 | 109699.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Immutep Ltd. | 3.09 |
| Ceryvyn Therapeutics Ltd. | 0.018 |
| Propanc Biopharma, Inc. | 1.82 |
| Mesoblast Ltd. | 15.00 |
| Actinogen Medical Ltd. | 0.0293 |
Price Related Metrics
| PS Ratio | 4.292 |
| Price to Free Cash Flow | 30.12 |
| Earnings Yield | -3.87% |
| Market Cap | 67.05B |
| Operating PE Ratio | 16.86 |
| Normalized PE Ratio | 23.56 |